Novogene is a leading provider of genomic services and solutions offering extensive next generation sequencing (NGS) capacity and bioinformatics expertise....
Fluor Corporation announced that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Co...
Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...
“This collaboration between Revvity and Element Biosciences seeks to elevate the overall customer experience by providing compelling application-spec...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs (including but not limited to...
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport...
BIOVECTRA and Acuitas Therapeutics, Inc. announced that they have entered into a technology transfer service agreement under which BIOVECTRA will acc...
The milestone payment of $1 million is the result of the successful achievement of a clinical development milestone for a gene therapy product based o...
“This reanalysis indicates that patients undergoing molecular testing at laboratories using CAP PT can continue to be confident that their test resul...
Charles River Laboratories International, Inc. announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The pl...
Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...
Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to c...
CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and continues SK pharmteco’s strategy to deliver end-to-end, multi-mod...
© 2024 Biopharma Boardroom. All Rights Reserved.
